Compare Enact Holdings Inc (ACT) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enact Holdings Inc vs GSK plc — how do they compare? Enact Holdings Inc trades at $49.07 (market cap $6.75B), while GSK plc trades at $50.56 (market cap $102.60B). The key difference: GSK plc is far larger — about 15.2× Enact Holdings Inc's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| ACT | GSK | |
|---|---|---|
Market Cap | $6.75B | $102.60B |
Sector | Technology | Health |
52-Week High | $49.12 | $61.18 |
52-Week Low | $34.93 | $38.22 |
Enterprise Value | $7.05B | $123.04B |
Dividend Yield | 1.95% | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enact Holdings Inc
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
